Added to YB: 2019-09-14
Pitch date: 2019-09-14
FBRX:US [bullish]
Forte Biosciences, Inc.
-81.9%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Forte Biosciences, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for autoimmune and autoimmune-related diseases.
Market Cap
$1.9B
Pitch Price
$425.25
Price Target
N/A
Dividend
N/A
EV/EBITDA
-18.38
P/E
-16.94
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Forte Biosciences Inc. FBRX:US
A summary for this pitch has not been created yet.
Read full article (0 min)